THP Activators
THP activators encompass a diverse group of chemical compounds that either directly or indirectly influence the expression and activity of Tamm-Horsfall protein (THP), a glycoprotein involved in renal function and the modulation of urinary tract homeostasis. While the identification of direct activators may be limited, these chemicals offer insights into potential regulatory mechanisms affecting THP. Retinoic Acid and its isomer, ATRA, both act through retinoic acid receptors, potentially activating THP by contributing to its expression and functional activity. These compounds operate within the intricate network of retinoic acid signaling pathways, influencing THP transcriptional regulation and impacting cellular processes related to THP. Inhibitors such as SB203580, PD98059, and SP600125 target key kinases in pathways connected to THP signaling, including p38 MAPK, MAPK/ERK, and JNK. By disrupting these pathways, these inhibitors may indirectly influence THP activity, altering downstream signaling cascades that impact THP expression in various cellular contexts.
GW9662 and Rosiglitazone act as modulators of peroxisome proliferator-activated receptors (PPARs), influencing THP transcriptional regulation. GW9662, a PPARγ antagonist, can potentially activate THP by inhibiting the negative regulatory influence of PPARγ, while Rosiglitazone, a PPARγ agonist, engages PPARγ, promoting THP expression and contributing to its functional activity in specific cellular environments. Histone deacetylase inhibitors, Trichostatin A and TSA, play a role in epigenetic modifications influencing THP gene regulation. These compounds prevent HDAC-mediated deacetylation of histones, promoting an open chromatin structure that facilitates THP expression and contributes to its functional activity. Furthermore, Celecoxib, a selective COX-2 inhibitor, may indirectly activate THP by modulating inflammatory pathways associated with THP regulation. The impact of these chemicals on THP provides valuable insights into the intricate regulatory mechanisms governing THP expression and function, contributing to a better understanding of urinary tract homeostasis and renal function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of vitamin A, can influence THP expression. It acts through retinoic acid receptors, modulating cellular processes involved in THP regulation. By binding to these receptors, Retinoic Acid potentially activates THP, contributing to its expression and function within the cellular environment. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 mitogen-activated protein kinase (MAPK), a pathway implicated in THP regulation. By blocking p38 MAPK, SB203580 may indirectly influence THP activity, altering downstream signaling cascades that impact THP expression and function in various cellular contexts. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 acts as a selective antagonist of peroxisome proliferator-activated receptor gamma (PPARγ). Since PPARγ is involved in THP transcriptional regulation, GW9662 can potentially activate THP by inhibiting the negative regulatory influence of PPARγ, allowing for enhanced THP expression and function in specific cellular environments. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinase (PI3K), a pathway connected to THP signaling. By disrupting PI3K, LY294002 may indirectly affect THP activity through shared downstream effectors, potentially influencing cellular processes regulated by THP. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. As epigenetic modifications play a role in THP gene regulation, Trichostatin A may activate THP by preventing HDAC-mediated deacetylation of histones, promoting an open chromatin structure that facilitates THP expression and contributes to its functional activity. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, an agonist of peroxisome proliferator-activated receptor delta (PPARδ), is implicated in THP regulation. By activating PPARδ, GW501516 may influence THP expression, potentially enhancing its activity in various cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits mitogen-activated protein kinase kinase (MEK), a kinase involved in the MAPK/ERK pathway associated with THP signaling. By blocking MEK, PD98059 may indirectly influence THP activity through shared downstream effectors, potentially modulating cellular processes regulated by THP. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), a kinase implicated in THP signaling. By blocking JNK, SP600125 may indirectly affect THP activity through shared downstream effectors, potentially modulating cellular processes regulated by THP. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a thiazolidinedione that acts as a PPARγ agonist. As PPARγ is involved in THP transcriptional regulation, Rosiglitazone can potentially activate THP by engaging PPARγ, influencing THP expression and contributing to its functional activity in specific cellular environments. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 inhibits transforming growth factor-beta (TGF-β) type I receptor, a component of the TGF-β signaling pathway implicated in THP regulation. By blocking this receptor, SB431542 may indirectly influence THP activity through shared downstream effectors, potentially modulating cellular processes regulated by THP. | ||||||